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ABSTRACT 
There is clear evidence that survival rates following transplantation far 
exceed those for remaining on dialysis, regardless of body size measured 
by body mass index (BMI). Studies over the past 15 years also suggest 
little to no difference in long-term outcomes, including graft survival and 
mortality, irrespective of BMI, in contrast to earlier evidence. However, 
weight bias still exists, as access to kidney transplantation remains 
inequitable in centres using arbitrary BMI limits. Clinicians faced with 
the decision regarding listing based on body size are not helped by 
conflicting recommendations in national and international guidelines. 
Therefore, in clinical practice, obesity, and recommendations for weight 
loss, remain a controversial issue when assessing suitability for kidney 
transplantation.  
 
Obesity management interventions in end-stage kidney disease (ESKD), 
whether for weight loss for transplantation listing or for slowing kidney 
disease progression, are under-explored in trial settings.  Bariatric surgery 
is the most successful treatment for obesity, but carries increased risk in 
the ESKD population, and the desired outcome of kidney transplant 
listing is not guaranteed.  Centers that limit transplants to those meeting 
arbitrary levels of body mass, rather than adopting an individualised 
assessment approach, may be unfairly depriving many ESKD patients of 
the survival and quality of life benefits derived from kidney 
transplantation. However, robotic kidney transplantation surgery holds 
promise for reducing perioperative risks related to obesity, and may 
therefore represent an opportunity to remove listing criteria based on size.  
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The use of BMI as an assessment criterion for kidney transplantation is 
out of step with current practice, which favors a personalized medicine 
approach.   BMI, originally derived as a measure predictive of population 
level mortality risk, is now widely used as a surrogate for obesity; issues 
with the appropriateness of this will not be considered here [1].  This 
paper explores this evidence regarding obesity as a risk factor for post-
transplant outcomes, graft survival and mortality. 
 
Clinical Practice Guidelines for transplant assessment generally 
recommend an individualised approach to determining suitability based 
on body weight, shape and size; however, they are plagued by moderate-
to-low certainty evidence, which leads to inconsistencies in practice, 
often resulting in recommendations for weight loss prior to kidney 
transplant waitlisting.  
 
 The UK Renal Association (UK-RA) [2] and the Kidney Health 
Australia – Caring for Australasians with Renal Impairment (KHA-
CARI) [3] both recommend that obesity by itself (defined as a BMI 
≥30kg/m2) should not preclude listing for transplantation (UK-RA and 
CARI, GRADE 2B and 1B, respectively), and that assessment should be 
individualised and cardiovascular risk factors be considered (2B and 1C).  
Both also suggest that the positive outcomes of transplantation may be 
diminished in those with a BMI > 40kg/m2 (2B and 1C). 
 
The European Renal Best Practice guideline group (ERBP) state that the 
association between BMI and patient survival is uncertain, and refrained 
from making a guideline statement on kidney transplant listing based on 
obesity itself [4]. Instead, they took the approach of recommending 
weight loss for potential candidates with a BMI >30 kg/m2 (ungraded), 
cautioning against pharmacological therapy and bariatric surgery due to 
the increased risks associated with these treatments.   
 
 
Obesity and kidney transplant outcomes 
Recent systematic reviews on kidney transplant outcomes demonstrate an 
increased risk of delayed graft function with obesity [5-8]; however, the 
data on mortality and graft survival are less clear [5-12]. The inconsistent 
conclusions appear to be related to methodological differences of 
inclusion criteria, date range and statistical analyses. In 2014, Nicoletto et 
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al reported that obesity did not impact upon death or graft loss in studies 
published since 2003 [6]. However, in studies published prior to 2003, 
obesity (BMI >30kg/m2) was associated with more death and graft loss 
than was seen in those having a normal BMI range [6].  Meta analyses 
conducted by Lafranca et al (2016) and Sood et al (2015) report an 
increased unadjusted risk ratio (RR) and fully adjusted hazard ratio (HR) 
respectively, for mortality, with BMI >30kg/m2 [5, 7]. However, neither 
study split the analysis into “modern” and “older” transplantation eras, 
which may explain the difference in mortality risk between these studies 
and that conducted by Nicoletto et al.   
 
The combined risk ratio reported by Lafranca et al suggested an 
association of obesity with an increased mortality risk (RR 1.52; 95% CI 
1.14-2.03) [7].  In the same study, the meta analysis of studies using fully 
adjusted regression analysis  (rather than an absolute risk ratio) 
demonstrated no association between obesity and mortality after kidney 
transplantation (HR 1.10; 95% CI 0/89-1.15). This finding concurred 
with that of Hill et al, who used a similar methodology (HR 1.24; 95%CI 
0.9-1.7) [8].  All of these reviews have suggested that it is factors 
associated with obesity, rather than obesity per se, that explains the 
differences between studies that have adjusted for potential confounders 
and those which have not.   
 
Similarly, conflicting results are reported for BMI and graft survival.  
Meta-analyses indicate a small reduction in the unadjusted risk of graft 
failure in lower compared to higher BMI recipients (RR 0.97; 95% CI 
0.96-0.99) [7] and a small increased risk of graft loss with higher BMI 
(adjusted HR 1.06; 95% CI 1.01-1.12) [8]; yet in the seven studies using 
generalized linear modeling there was no difference in graft survival 
between low and high BMI (HR 1.00; 95% CI 0.96-1.04) [7]. Studies 
based on US transplant recipient databases all demonstrate an increased 
risk of, or shorter time to, graft failure with increasing BMI [9-11].  In 
those with a BMI > 50 kg/m2, the risk of 30-day perioperative mortality, 
length of hospital stay, delay in graft function and 1, 3 and 5 year 
mortality were all significantly greater than in any other BMI group [13].  
  
Conversely, using data extracted from the UK Renal Registry and the 
National Health Service Blood and Transplant (NHSBT) database for the 
UK transplant recipient population, fully adjusted hazard ratios for graft 
survival and patient survival did not differ across BMI bands in 
transplanted patients, up to BMI >40kg/m2 [12].  It may be relevant that 
this study included participants transplanted from 2004 onwards. 
Furthermore, the authors suggest that the differences in their findings 
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when compared to other registry studies may be attributed to robust 
cardiovascular assessment of all potential transplant recipients in the UK. 
 
Regardless of these contrasting (and, when present, relatively minor) 
findings for graft and patient survival after transplantation, there is clear 
evidence indicating that outcomes after transplantation are superior to 
those on dialysis, at any level of BMI [12, 14].  There was a significant 
survival benefit, in fully adjusted analyses, across all BMI categories for 
all types of transplant, compared to remaining on the waitlist, in both the 
UK [12] and US registry-based studies [14]. Survival at 1 and 5 years 
improved across BMI categories up to BMI >40kg/m2, compared with 
remaining on dialysis, and there was no level of BMI at which this 
survival benefit was not evident [12].  One caveat appeared in the sub-
group of black patients with BMI ≥40 kg/m2, with no survival advantage 
with transplantation over dialysis; however, this analysis is likely to be 
underpowered given the small sample size of this group [14].    
 
Weight bias in transplantation and transplant listing  
In patients with high BMI, listing for transplantation remains biased 
against this group despite clear evidence of a survival advantage over 
remaining on dialysis.  In the US, the proportion of wait-listed patients 
receiving a transplant peaks at 69% when BMI is <18.5kg/m2, then 
decreases steadily as BMI increases, down to a low of 45% when BMI 
is ≥ 40 kg/m2 [15].  Up to 30% of exclusions from transplant listing can 
be attributed to obesity [16].  Data from the French Renal and 
Epidemiology Information Network (REIN) indicate that, after 
adjustment for potential confounding variables, the likelihood of 
transplantation falls as BMI increases above 30 kg/m2.  Patients with a 
BMI of >31kg/m2 are more likely to remain on dialysis than receive a 
kidney transplant (HR <1) [17].  Beyond this, patients with a BMI ≥40 
kg/m2 were half as likely to undergo transplantation than those with a 
BMI between 21-31 kg/m2 [17].  Furthermore, in those with a BMI ≥ 
30kg/m2 each 1kg/m2 decrease in BMI is associated with a 9-11% 
increase in the likelihood of transplantation.  
 
Weight bias in kidney transplantation waitlisting likely exists due to the 
short-term complications such as higher rates of wound complications, 
longer hospital stay and delayed graft function.  These factors have a 
direct impact on transplant centre costs and measures of quality and 
excellence; avoiding transplantation in high BMI patients may be 
practiced in an attempt to improve these measures [18].  Weight bias is 
also based on outcome data from “older” eras of transplantation, that 
likely differ from outcomes in during the “modern” era (the last 15 years) 
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of kidney transplantation.  There appears to be consistency in the findings 
of studies using data from the early 2000s onwards, demonstrating no 
difference in patient or graft survival with obesity, compared to the 
normal BMI category as the reference standard [6, 12]. This equivalence 
of outcomes is largely supported by the systematic review of findings 
using multivariate analyses adjusted for likely confounding variables [7, 
8].    
 
Weight management options – from lifestyle to bariatric surgery  
As BMI remains as a gatekeeper for transplant listing, weight loss 
interventions, including bariatric surgery, must be undertaken to improve 
the likelihood for kidney transplant listing for individuals.  This is the 
case even though well-conducted, prospective studies of intentional 
weight loss on short and long term post transplant outcomes are lacking.  
Successful transplantation listing after bariatric surgery has been reported 
in several studies; many of these are small case series, with 55-100% of 
those undergoing bariatric surgery being listed for, or receiving a kidney 
transplant during follow up [19-24]. 
 
More modest weight loss has been recorded with lifestyle approaches 
including dietary intervention with or without exercise. Weight 
management approaches in the CKD population are most frequently 
assessed prior to dialysis and appear to promote weight loss in a range of 
2-10%, sustained for up to 24 months [25-26]. In this weight loss range, 
several studies have demonstrated improved metabolic health [25-26]. 
However, this field is limited by small RCTs with high risk of bias, with 
limited focus on transplant listing as outcomes.  
 
Although bariatric surgery may be able to help patients become listed for 
or receive kidney transplants, the risks involved from such surgery for 
people with kidney disease exceed those of the general population.  
Complications increase as kidney function declines, with almost a 10% 
increased absolute risk of complication post bariatric surgery in those 
with stage 5 CKD [27].  Risk of mortality post bariatric surgery is 11 
times higher in those with ESKD compared to those without CKD, with 
the absolute rate increasing from 12 to 157 deaths per 1000 person years 
[28].  These risks, as well as potential benefits should be explained to, 
and understood by, individuals as part of decision-making process.   
 
Use of specialised centres for bariatric surgery in ESKD may reduce 
operative complications and length of stay.  Improvements occurred in 
the last 25 patients compared to the first 25 in a series of 100 patients 
with CKD undergoing bariatric surgery in a single centre, identifying a 
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learning curve for surgery in this specific patient population [29]. Risk 
minimisation protocols may also help to identify and reduce risk. The 
London Renal Obesity Network developed a joint surgical and 
nephrology protocol for patients with CKD undergoing bariatric surgery. 
They outline the steps to be taken for assessment, preparation and post 
operative monitoring, to improve clarity around management of renal 
specific issues including, but not limited to, robust cardiovascular risk 
assessment and fluid management [30].   
 
Many individuals and some guideline groups advocate for assessment of 
a patient’s suitability for kidney transplantation on an individualized basis 
considering metabolic fitness and surgical feasibility.  However, 
unwarranted bias in wait listing continues to exist due to arbitrary BMI 
limits, and bariatric surgery often needs to be considered. However, 
before bariatric surgery is routinely recommended based on BMI alone to 
ESKD patients seeking kidney transplantation, robust evidence from 
prospective studies of improvements in patient focused outcomes and 
long-term safety is required [31].   
 
Could robotic transplants address the issue? 
Robotic surgery shows promise as a solution to the problem of body size 
impeding kidney transplantation. Several studies have demonstrated 
significantly fewer, and often no, site infections in obese, robotic 
transplant recipients [32-34]. Outcomes up to 5 years post robotic-
assisted transplantation have also been studied. Median BMI in the 
robotic cases was significantly higher than on the open controls  (BMI; 
42.3 (31.1-64.3) vs 36.8 (30.0-51.1)), yet there was no difference in 
patient and graft survival or transplant rejection at 5 years between 
groups [33]. Similarly, using data from the UNOS registry in the US from 
patients with BMI >40 kg/m2, with higher BMI in the robotic transplant 
group compared to open surgery, there was no difference in patient or 
graft survival, or kidney function at 3 years post transplant [34]. 
 
Is it time to limit body weight bias in kidney transplantation? 
Bariatric surgery does lead to effective weight loss in patients with 
ESKD, but is not without risk and, of course, does not guarantee 
transplantation.  Benefits may only outweigh the risks when the end goal 
of transplantation is achieved.  In order to avoid potentially unwarranted 
weight loss surgery, referral to a specialist centre for robotic surgery 
should be considered in patients whose BMI is > 40kg/m2; this may help 
reduce the current trend towards bariatric surgery. With robust pre-
transplant recipient assessment, sound medical management, risk 
assessment and modern era immunosuppression, weight loss prior to 
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transplantation is unlikely to further improve outcomes, and can increase 
the time on dialysis prior to transplantation. Certainly, when 
individualized assessment and cardiovascular disease risk assessment 
does not preclude transplantation, listing should occur without reference 
to BMI, provided all other listing assessment criteria are met.    
 
This area is ripe for new research to address many of the conundrums 
faced. First, there is a need to continue to evaluate outcomes from robotic 
transplant procedures. Second, further evaluation of frailty and functional 
capacity, independent of body size, on transplant outcomes is needed.   
This may pave the way for clinical trials using nutrition and exercise 
interventions pre-transplant, with a focus on more patient-centered 
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